Validation of the Chinese Version of the 16-Item Negative Symptom Assessment
Authors Huang B, Wang Y, Miao Q, Yu X, Pu C, Shi C
Received 25 February 2020
Accepted for publication 8 April 2020
Published 4 May 2020 Volume 2020:16 Pages 1113—1120
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Yuping Ning
Bing-jie Huang,1– 4 Yong Wang,1– 4 Qi Miao,1– 4 Xin Yu,1– 4 Cheng-cheng Pu,1– 4 Chuan Shi1– 4
1Clinical Research Department, Peking University Sixth Hospital, Beijing, People’s Republic of China; 2Institute of Mental Health, Peking University, Beijing, People’s Republic of China; 3NHC Key Laboratory of Mental Health (Peking University), , Beijing, People’s Republic of China; 4National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, People’s Republic of China
Correspondence: Cheng-cheng Pu; Chuan Shi Email email@example.com; firstname.lastname@example.org
Purpose: The Negative Symptom Assessment-16 (NSA-16) is an instrument with significant validity and utility for assessing negative symptoms associated with schizophrenia. This study aimed to validate the Chinese version of the NSA-16.
Patients and Methods: A total of 172 participants with schizophrenia were assessed with the NSA-16, Scale for Assessment of Negative Symptoms (SANS), Positive and Negative Syndrome Scale (PANSS), Calgary Depression Scale for Schizophrenia (CDSS) and Rating Scale for Extrapyramidal Side Effects (RSESE). The factor structure of the NSA-16 was evaluated via exploratory and confirmatory factor analysis. Cronbach’s α and intraclass correlation coefficients were computed. Correlations were evaluated via Spearman correlation coefficient.
Results: The original five-factor model of the NSA-16 did not fit our sample. Exploratory factor analysis followed by confirmatory factor analysis suggested a three-factor structure, consisting of communication, emotion and motivation, with 15 items. The NSA with 15 items was termed as the NSA-15. The NSA-15 showed excellent convergent validity by high correlations with the SANS and PANSS total and negative factor scores and good divergent validity by independence from the PANSS positive factor, CDSS and RSESE. The NSA-15 showed good internal consistency, interrater reliability and test–retest reliability.
Conclusion: The NSA-15 is best characterized by a three-factor structure and is valid for assessing negative symptoms of schizophrenia in Chinese individuals.
Keywords: negative symptoms, schizophrenia, NSA, reliability, validity
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]